Publication | Closed Access
Enhanced Atherosclerosis in TIPE2-Deficient Mice Is Associated with Increased Macrophage Responses to Oxidized Low-Density Lipoprotein
66
Citations
22
References
2013
Year
Macrophage ResponsesLipid PeroxidationImmunologyImmune RegulationRenal InflammationOxidative StressInflammationMetabolic SyndromeOxidized Low-density LipoproteinMetabolic SignalingCell SignalingAtherosclerosisDyslipidemiaMolecular SignalingHealth SciencesMolecular PhysiologyChronic InflammationVascular BiologyTipe2 DeficiencyEnhanced AtherosclerosisInflammatory DiseaseCell BiologyAtherosclerosis DevelopmentPhysiologyEndothelial DysfunctionLipoprotein MetabolismMedicine
Atherosclerosis has been widely recognized as an inflammatory disease of the arterial wall in which macrophages play a major role. Yet, how macrophage-mediated pathology is regulated during atherosclerosis is poorly understood. TNF-α-induced protein 8-like 2 (TIPE2, also known as TNFAIP8L2) is highly expressed in resting macrophages and can negatively regulate inflammation through inhibiting immune receptor signaling. We report in this article that TIPE2 plays a crucial atheroprotective role likely by regulating macrophage responses to oxidized low-density lipoprotein (ox-LDL). TIPE2-deficient macrophages treated with ox-LDL produced more oxidative stress and proinflammatory cytokines, and exhibited heightened activation of the JNK, NF-κB, and p38 signaling pathways. As a consequence, TIPE2 deficiency in bone marrow-derived cells exacerbated atherosclerosis development in Ldlr(-/-) mice fed a high-fat diet. Importantly, ox-LDL markedly downregulated TIPE2 mRNA and protein levels in macrophages, suggesting that ox-LDL mediates atherosclerosis by TIPE2 inhibition. These results indicate that TIPE2 is a new inhibitor of atherosclerosis and a potential drug target for treating the disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1